8 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... and Secondary End ... Points #EBM #Neuro ... #IM #Fremanezumab ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... and Secondary End ... Points #EBM #Neuro ... #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Fremanezumab for ... to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
Dizziness #Diagnosis #PrimaryCare ... #EM #IM #Differential ... Lightheadedness #Table #NEJM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
Nonvertebral Fracture #EBM ... #PrimaryCare #Endo ... #IM #Romosozumab ... #Alendronate #NEJM
Suspected sepsis: Summary of NICE guidlelines #Diagnosis #Management #EM #IM #PrimaryCare #Sepsis #NICE #Monitoring #BMJ
guidlelines #Diagnosis #Management ... #EM #IM #PrimaryCare
Management of type 2 diabetes in adults: summary of updated NICE guidance #Management #IM #PrimaryCare #Endo
Management of type ... NICE guidance #Management ... #IM #PrimaryCare ... #Endo #DM2 #BMJ
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
of the primary end ... warfarin (Panel A) #EBM ... #Cardiology #IM ... AtrialFibrillation #NEJM